We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Offers Guidance on Developing Drugs for Celiac Disease
CDER Offers Guidance on Developing Drugs for Celiac Disease
The FDA’s Center for Drug Evaluation and Research (CDER) has issued draft guidance for industry on developing medicines that can be used for the treatment of celiac disease (CeD) along with a gluten-free diet.